Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Fmr LLC

Fmr LLC raised its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 3.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,311,867 shares of the company’s stock after purchasing an additional 546,869 shares during the quarter. Fmr LLC owned about 14.40% of Surgery Partners worth $590,375,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of SGRY. Vanguard Group Inc. increased its stake in shares of Surgery Partners by 0.8% during the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after acquiring an additional 61,400 shares during the period. Clearbridge Investments LLC increased its stake in shares of Surgery Partners by 1.3% during the second quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock worth $132,880,000 after acquiring an additional 73,007 shares during the period. Deerfield Management Company L.P. Series C increased its stake in shares of Surgery Partners by 47.7% during the second quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock worth $111,986,000 after acquiring an additional 1,520,484 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Surgery Partners by 26.7% during the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock worth $66,643,000 after acquiring an additional 589,499 shares during the period. Finally, Victory Capital Management Inc. increased its stake in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after acquiring an additional 777,038 shares during the period.

Surgery Partners Stock Up 2.3 %

Shares of NASDAQ SGRY opened at $23.41 on Friday. Surgery Partners, Inc. has a 12-month low of $21.36 and a 12-month high of $36.92. The company has a market capitalization of $2.98 billion, a PE ratio of -48.77, a price-to-earnings-growth ratio of 19.47 and a beta of 2.76. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm’s 50-day moving average is $29.15 and its two-hundred day moving average is $28.24.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. During the same period last year, the company earned $0.15 EPS. The firm’s revenue for the quarter was up 14.3% on a year-over-year basis. Equities analysts anticipate that Surgery Partners, Inc. will post 0.73 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SGRY. Citigroup dropped their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Macquarie reissued an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. KeyCorp started coverage on shares of Surgery Partners in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, UBS Group started coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus target price of $38.71.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.